Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
The EMBO Journal
|
October 23, 2010
Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans
Sabine Lagger, Dominique Meunier, Mario Mikula, et al.
The EMBO Journal
|
November 19, 2013
Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
Mircea Winter, Mirjam A Moser, Dominique Meunier, et al.
Journal of Cellular Physiology
|
March 17, 2017
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals
Josef Večeřa, Eva Bártová, Jana Krejčí, et al.
Development (Cambridge, England)
|
January 23, 2014
A single allele of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralog
Astrid Hagelkruys, Sabine Lagger, Julia Krahmer, et al.
Annals of Clinical and Translational Neurology
|
May 3, 2020
Vorinostat in the acute neuroinflammatory form of X-linked adrenoleukodystrophy
Bettina Zierfuss, Isabelle Weinhofer, Jörn-Sven Kühl, et al.
Plos Genetics
|
March 8, 2012
A downstream CpG island controls transcript initiation and elongation and the methylation state of the imprinted Airn macro ncRNA promoter
Martha V Koerner, Florian M Pauler, Quanah J Hudson, et al.
Journal of Autoimmunity
|
October 2, 2017
A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis
Lisa Göschl, Teresa Preglej, Patricia Hamminger, et al.
Nature Immunology
|
April 1, 2014
CD4(+) T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2
Nicole Boucheron, Roland Tschismarov, Lisa Goeschl, et al.
Journal of Autoimmunity
|
February 23, 2021
Histone deacetylase 1 controls CD4<sup>+</sup> T cell trafficking in autoinflammatory diseases
Patricia Hamminger, Luca Marchetti, Teresa Preglej, et al.
Leukemia
|
April 2, 2025
HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy
Maša Zrimšek, Kristina Draganić, Anna Malzer, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
The EMBO Journal
|
October 23, 2010
Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans
Sabine Lagger, Dominique Meunier, Mario Mikula, et al.
The EMBO Journal
|
November 19, 2013
Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
Mircea Winter, Mirjam A Moser, Dominique Meunier, et al.
Journal of Cellular Physiology
|
March 17, 2017
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals
Josef Večeřa, Eva Bártová, Jana Krejčí, et al.
Development (Cambridge, England)
|
January 23, 2014
A single allele of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralog
Astrid Hagelkruys, Sabine Lagger, Julia Krahmer, et al.
Annals of Clinical and Translational Neurology
|
May 3, 2020
Vorinostat in the acute neuroinflammatory form of X-linked adrenoleukodystrophy
Bettina Zierfuss, Isabelle Weinhofer, Jörn-Sven Kühl, et al.
Plos Genetics
|
March 8, 2012
A downstream CpG island controls transcript initiation and elongation and the methylation state of the imprinted Airn macro ncRNA promoter
Martha V Koerner, Florian M Pauler, Quanah J Hudson, et al.
Journal of Autoimmunity
|
October 2, 2017
A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis
Lisa Göschl, Teresa Preglej, Patricia Hamminger, et al.
Nature Immunology
|
April 1, 2014
CD4(+) T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2
Nicole Boucheron, Roland Tschismarov, Lisa Goeschl, et al.
Journal of Autoimmunity
|
February 23, 2021
Histone deacetylase 1 controls CD4<sup>+</sup> T cell trafficking in autoinflammatory diseases
Patricia Hamminger, Luca Marchetti, Teresa Preglej, et al.
Leukemia
|
April 2, 2025
HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy
Maša Zrimšek, Kristina Draganić, Anna Malzer, et al.
Page
of 7